Assessment of Dissociative Traumatic Disorders

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-02-05

Study Completion Date

2021-09-05

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

More than 70% of ambulatory patients with IDD have attempted suicide (APA, 2015). This disorder, as well as all the disorders on the dissociation spectrum, must therefore be clarified and better diagnosed.

The goal of this research is :

1. to assess the prevalence of dissociative disorders using specific tools in patients suffering from PTSD.
2. to validate the French version of the DDIS interview (Ross, 1997) that the investigators have translated.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Prevalence of Dissociative Identity Disorder in At-risk Outpatient Groups Reporting Childhood Trauma.

NCT06330467

Dissociative Disorder

RECRUITING NA

Evaluating the Neurobiological Basis of Traumatic Dissociation in Women With Histories of Abuse and Neglect

NCT02757339

Posttraumatic Stress Disorders Dissociative Identity Disorder

ENROLLING_BY_INVITATION

Identification of Post-Traumatic Stress Disorder in Adult Patients With Substance Use Disorders

NCT06432400

Trauma

WITHDRAWN NA

Early Detection of Patients at Risk of Developing a Post-traumatic Stress Disorder After a Stay in Intensive Care Unit

NCT03278171

Post Traumatic Stress Disorder

COMPLETED

Evaluation of the Effects of Post-Immediate Psychotherapeutic Interventions in Secondary Prevention of Psychotraumatic Disorders

NCT00455390

PTSD Post Traumatic Syndrome Disorder

UNKNOWN PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Posttraumatic Stress Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

All patients with a diagnosis of Post Traumatic Stress Disorder will be seen by a physician psychiatrist or psychologist who will introduce them to the study. They will be given an information letter and a consent form. If patients agree to participate in the study, and after signing the consent form, they will be included and will complete the assessment scales.

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Posttraumatic stress disorder

cohort of patients with Posttraumatic stress disorder PTSD

Group Type OTHER

self-assessment and hetero-assessment

Intervention Type OTHER

Self assessment for the passing of the following rating scales CTQ-SF36-ITQ-PCL5-DES Hetero-assessment for the pasing of the following rating scales DDIS FR and medical interview

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

self-assessment and hetero-assessment

Self assessment for the passing of the following rating scales CTQ-SF36-ITQ-PCL5-DES Hetero-assessment for the pasing of the following rating scales DDIS FR and medical interview

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient diagnosed with PTSD according to DSM 5 criteria
* Over 18 years of age
* Informed consent signed

Exclusion Criteria

* Neurological disorders
* Serious and/or unstable somatic pathologies
* Patient not affiliated with social security
* Patient hospitalized under restraint in psychiatric care by decision of the state representative or in psychiatric care at the request of a third party
* Patient under guardianship
* Patient participating in parallel in another biomedical research
* Change of antidepressant in the last three months
* Patient not mastering the French language

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No